± HEALTH In our modern society, digital devices, social media platforms, and artificial intelligence (AI) tools have b…+ CLIMATE The growing complexity of electric vehicle charging station (EVCS) operations—driven by grid constraints, ren…± HEALTH Objectives This study aim to develop, compare and internally validate machine-learning models for predicting…+ HEALTH Diabetes management faces a number of obstacles, such as fragmented healthcare data, privacy concerns, poor e…− SCIENCE Background Craniofacial soft tissue thickness (CFSTT) is a critical parameter in forensic facial reconstructi…+ HEALTH Background Technological innovation in total joint arthroplasty (TJA) has largely focused on intraoperative p…± HEALTH Infective endocarditis (IE) continues to be an often fatal condition despite improvements in cardiac surgical…± HEALTH Purpose of review Systemic sclerosis-associated interstitial lung disease (SSc-ILD) is the leading cause of d…
TruaceTracing the truth around AISaturday, September 12, 2026
Subscribe
TRV-2026-1046Certified recordPeer-reviewed

Stakeholder perspectives on artificial intelligence in schizophrenia care

Background Artificial intelligence (AI) is explored as a tool to expand access to mental health care, offering support and self-disclosure. To date, the perspectives of individuals with schizophrenia on AI have been absent from the medical literature. This exploratory study represents an effort to report schizophrenia patient perspectives on AI chatbots through a focus group. Methods We conducted an exploratory, cross-sectional, qualitative study using semi-structured focus groups at a large academic health cent…

Health · The Trace — both readings · certified 2026-09-10 · v1 · article view · machine-readable

Current reading — gain

Participants with schizophrenia recognized an AI companion as a potentially accessible source of support between clinical visits.

Current reading — problem

Participants identified trust as the central barrier to using an AI companion, driven by privacy concerns and vulnerabilities specific to schizophrenia.

What this doesn’t fix

Findings are exploratory and based on a small, single-site qualitative sample, limiting generalizability beyond this New York City academic center.

Evidence

Reader signal

How should this claim be treated?

Cite this record

Truvace Impact Record TRV-2026-1046, v1: “Stakeholder perspectives on artificial intelligence in schizophrenia care.” Truvace, 2026-09-10. /record/TRV-2026-1046 (accessed at citation time). sha256 582765e2b7a6a72d…

Calibration history

Every change to this record since certification, in the open. None yet — the reading has held since it entered the record.

  1. Certifiedv1582765e2b7a6…

    Certified into the record

Verify this record
How to verify without trusting this page

Fetch the canonical text of any version from /api/record/TRV-2026-1046 and hash it yourself — for example shasum -a 256 on the saved canonical field. The result must equal content_hash, and each version’s text ends with prev:followed by the prior version’s hash (version 1 chains to 64 zeros). If a single character of any version had been altered since certification, the chain would not reproduce.